POIA
HAE icon

Pin Oak Investment Advisors’s Haemonetics HAE Stock Holding History

Pin Oak Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Hold
42
– – ﹤0.01% 469
2025
Q4 		$2K Sell
42
-65
-61% -$4.37K ﹤0.01% 474
2025
Q3 		$5.21K Buy
+107
New +$6.62K ﹤0.01% 424

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pin Oak Investment Advisors's HAE Position: Q1 2026 in Review

Pin Oak Investment Advisors held its Haemonetics (HAE) position steady in Q1 2026 at 42 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Pin Oak Investment Advisors first reported a position in HAE in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.21K in Q3 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Pin Oak Investment Advisors held 42 shares of Haemonetics worth $2K as of Q1 2026.
  • Pin Oak Investment Advisors left its Haemonetics share count unchanged in Q1 2026.
  • Haemonetics made up ﹤0.01% of Pin Oak Investment Advisors's portfolio in Q1 2026, its #469 holding.
  • Pin Oak Investment Advisors first reported a position in Haemonetics in Q3 2025 and has held it in 3 quarters since.
  • Pin Oak Investment Advisors's Haemonetics position peaked at $5.21K in Q3 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Pin Oak Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.